Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 400,000
-28,500 (-6.65%)
Last updated: Jun 10, 2026, 2:01 PM KST
Hanmi Pharm. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,217,908 | 5,731,457 | 3,556,800 | 4,473,421 | 3,711,167 | 3,373,870 | |
Market Cap Growth | 42.63% | 61.14% | -20.49% | 20.54% | 10.00% | -23.27% |
Enterprise Value | 5,516,727 | 6,103,460 | 4,027,046 | 4,935,354 | 4,226,778 | 4,030,879 |
Last Close Price | 411500.00 | 450353.37 | 279478.14 | 349622.87 | 289351.69 | 262307.54 |
PE Ratio | 30.28 | 33.80 | 29.32 | 30.59 | 44.83 | 50.34 |
Forward PE | 27.35 | 33.64 | 19.54 | 30.57 | 38.01 | 44.63 |
PS Ratio | 3.37 | 3.70 | 2.38 | 3.00 | 2.79 | 2.80 |
PB Ratio | 3.53 | 4.03 | 2.87 | 4.07 | 3.68 | 3.64 |
P/TBV Ratio | 4.18 | 4.78 | 3.42 | 4.92 | 4.51 | 4.47 |
P/FCF Ratio | 33.90 | 44.07 | 23.06 | 23.65 | 28.14 | 18.54 |
P/OCF Ratio | 25.41 | 33.12 | 18.38 | 20.66 | 22.87 | 16.71 |
PEG Ratio | 1.24 | 1.58 | 1.16 | 1.08 | 0.37 | 0.37 |
EV/Sales Ratio | 3.56 | 3.94 | 2.69 | 3.31 | 3.17 | 3.35 |
EV/EBITDA Ratio | 17.82 | 18.92 | 13.00 | 15.26 | 16.86 | 18.79 |
EV/EBIT Ratio | 26.20 | 27.26 | 18.95 | 21.95 | 27.47 | 32.14 |
EV/FCF Ratio | 35.84 | 46.93 | 26.11 | 26.09 | 32.05 | 22.15 |
Debt / Equity Ratio | 0.28 | 0.31 | 0.40 | 0.52 | 0.67 | 0.82 |
Debt / EBITDA Ratio | 1.35 | 1.35 | 1.60 | 1.77 | 2.71 | 3.53 |
Debt / FCF Ratio | 2.72 | 3.34 | 3.22 | 3.03 | 5.14 | 4.16 |
Net Debt / Equity Ratio | 0.08 | 0.16 | 0.25 | 0.29 | 0.44 | 0.59 |
Net Debt / EBITDA Ratio | 0.39 | 0.72 | 0.98 | 0.98 | 1.76 | 2.54 |
Net Debt / FCF Ratio | 0.78 | 1.79 | 1.97 | 1.68 | 3.35 | 2.99 |
Asset Turnover | 0.74 | 0.74 | 0.76 | 0.78 | 0.69 | 0.63 |
Inventory Turnover | 2.03 | 2.07 | 2.30 | 2.38 | 2.37 | 2.04 |
Quick Ratio | 0.95 | 0.90 | 0.63 | 0.61 | 0.62 | 0.67 |
Current Ratio | 1.54 | 1.48 | 1.09 | 1.04 | 1.03 | 1.08 |
Return on Equity (ROE) | 14.09% | 14.05% | 12.00% | 15.68% | 10.48% | 9.26% |
Return on Assets (ROA) | 6.25% | 6.73% | 6.78% | 7.35% | 4.98% | 4.11% |
Return on Invested Capital (ROIC) | 11.61% | 12.26% | 11.77% | 13.37% | 8.83% | 6.66% |
Return on Capital Employed (ROCE) | 13.30% | 14.60% | 15.90% | 18.80% | 12.30% | 9.70% |
Earnings Yield | 3.30% | 2.96% | 3.41% | 3.27% | 2.23% | 1.99% |
FCF Yield | 2.95% | 2.27% | 4.34% | 4.23% | 3.55% | 5.39% |
Payout Ratio | 8.33% | 18.20% | 10.35% | 12.31% | 7.24% | 8.77% |
Buyback Yield / Dilution | -0.08% | -0.07% | 0.08% | 0.09% | 0.12% | 0.11% |